Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Strides Shasun seeks shareholders nod to change name to Strides Pharma Science

      Strides Shasun seeks shareholders nod to change name to Strides Pharma Science

      Ruby Khatun Khatun31 May 2018 10:00 AM IST
      New Delhi: Drug firm Strides Shasun has sought shareholders' nod to change its name to Strides Pharma Science.This is the second time in three years...
      Sanofi Genzyme partners with Multiple Sclerosis Society of India

      Sanofi Genzyme partners with Multiple Sclerosis Society of India

      Ruby Khatun Khatun31 May 2018 9:45 AM IST
      Mumbai: Sanofi Genzyme, the specialty care global business unit of Sanofi, and Multiple Sclerosis Society of India (MSSI) join hands to raise...
      Novo Nordisks oral diabetes drug beats Jardiance in study

      Novo Nordisk's oral diabetes drug beats Jardiance in study

      Ruby Khatun Khatun31 May 2018 9:30 AM IST
      LONDON/COPENHAGEN: Novo Nordisk said data from a large final-stage study of a pill it hopes will transform the diabetes market proved better at...
      EU makes it easier for companies to produce generic medicines for export

      EU makes it easier for companies to produce generic medicines for export

      Ruby Khatun Khatun30 May 2018 11:08 AM IST
      BRUSSELS: The European Commission on Monday proposed to change intellectual property rules to let pharmaceutical companies produce generic drugs for...
      Robots not a threat to human labour: Microsoft chief Satya Nadella

      Robots not a threat to human labour: Microsoft chief Satya Nadella

      Ruby Khatun Khatun30 May 2018 9:08 AM IST
      LONDON: Microsoft's Indian-origin chief, Satya Nadella, does not believe in the "fallacy" that robots will overtake human labour and is confident that...
      Seven Hills hospitals for Sale: Apollo Hospitals, Aster DM, Narayan Health initial bidders

      Seven Hills hospitals for Sale: Apollo Hospitals, Aster DM, Narayan Health initial bidders

      Ruby Khatun Khatun29 May 2018 4:51 PM IST
      MUMBAI: To acquire the assets of Seven Hills hospitals, several hospitals are vying for the race, according to a recent media report.Narayan Health is...
      MTaI welcomes government’s plan to regulate critical care medical devices

      MTaI welcomes government’s plan to regulate critical care medical devices

      Ruby Khatun Khatun29 May 2018 10:30 AM IST
      New Delhi: Medical Technology Association of India (MTaI), which represents leading research-based medical technology companies with significant...
      Fortis Healthcare undecided on reopening bidding process

      Fortis Healthcare undecided on reopening bidding process

      Ruby Khatun Khatun29 May 2018 10:15 AM IST
      BENGALURU: India’s Fortis Healthcare Ltd said it had not decided whether to re-open bidding for itself, after an offer of funding that its board had...
      Aurobindo Pharma Q4 net dips marginally to Rs 528 crore

      Aurobindo Pharma Q4 net dips marginally to Rs 528 crore

      Ruby Khatun Khatun29 May 2018 10:00 AM IST
      New Delhi: Aurobindo Pharma reported a marginal decline in its net profit at Rs 528.5 crore for the fourth quarter ended March 2018.The company had...
      FDA warns again OTC use of Teething products containing benzocaine

      FDA warns again OTC use of Teething products containing benzocaine

      Ruby Khatun Khatun29 May 2018 9:45 AM IST
      The U.S. Food and Drug Administration (FDA) is warning consumers that over-the-counter (OTC) teething products containing benzocaine pose a serious...
      Roches Tecentriq meets targets in lung cancer trial

      Roche's Tecentriq meets targets in lung cancer trial

      Ruby Khatun Khatun29 May 2018 9:30 AM IST
      ZURICH: A combination of Roche’s Tecentriq immunotherapy with chemotherapy helped people with a form of lung cancer live significantly longer than...
      Fortis Healthcare Bid Likely to open again

      Fortis Healthcare Bid Likely to open again

      Ruby Khatun Khatun28 May 2018 4:25 PM IST
      New Delhi: The bid for Fortis healthcare is likely to open again as the victorious bidders have given their nod to re-open the bidding process. In...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok